Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Casali, P.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(7)
+
-
Availability
Open access
(2)
+
-
Metadata Only
(5)
+
-
Creation Date
2016
(2)
+
-
2018
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(6)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(6)
+
-
Topic
Denosumab
(2)
+
-
Giant cell tumor of bone
(2)
+
-
Sarcoma
(2)
+
-
Author
Casali, P.
(7)
+
-
Gelderblom, H.
(6)
+
-
Blay, J.Y.
(5)
+
-
Rutkowski, P.
(5)
+
-
Cesne, A. le
(3)
+
-
Hohenberger, P.
(3)
+
-
Stacchiotti, S.
(3)
+
-
Badalamenti, G.
(2)
+
-
Baldi, G.G.
(2)
+
-
Blackstein, M.
(2)
+
-
Ferrari, S.
(2)
+
-
Gronchi, A.
(2)
+
-
Joensuu, H.
(2)
+
-
Kang, Y.K.
(2)
+
-
Kuss, I.
(2)
+
-
Leahy, M.
(2)
+
-
Mehren, M. von
(2)
+
-
Nishida, T.
(2)
+
-
Parry, M.
(2)
+
-
Reichardt, P.
(2)
+
-
Schoffski, P.
(2)
+
-
Xu, J.
(2)
+
-
Show more
Language
en
(7)
+
-
Search results
(1 - 7 of 7)
show grid
show list
save search
Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemothe
Results from a phase III trial (GRID) evaluating regorafenib in metastatic gastrointestinal stromal tumour (GIST): Subgroup analysis of outcomes based on pretreatment characteristics
Randomized phase 3 trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU) - GRID trial